Dear Eric: My wife and I will soon receive a small inheritance from the death of one of my relatives. Since we do not need most of this money, we have decided to distribute it among our children and ...

Explore whether a painting can still feel rich, expressive and complete when created under the strict limitation of only thirty brushstrokes. The challenge forces every movement to carry intention, ...

Jacksonville’s coach has his team in the AFC South driver’s seat. Plus, Daniel Jones’s future, Shedeur Sanders is earning his way and much more. When the sun sets on Week 14 on Monday night, ...

The Matrix, The Terminator—so much of our science fiction is built around the dangers of superintelligent artificial intelligence: a system that exceeds the best humans across nearly all cognitive ...

At Ford Field on Thursday, Amon-Ra St. Brown and the Detroit Lions (7-5) face Javonte Williams and the Dallas Cowboys (6-5-1) in a matchup featuring two of the brightest stars in the NFL, beginning at ...

In photographer Catherine Opie’s intimate series of images from inside Elizabeth Taylor’s home, one holds unexpected wisdom for jewelry collectors. A stack of boxes —mostly, it appears, for necklaces ...

THE YOUNG SOCIALISTS, the youth wing of Switzerland’s Social Democratic Party, do not have any MPs in parliament, but they know how to make a stir. On November 30th the country held a referendum on ...

This article has spoilers, so please, don’t scroll down unless you want to have it spoiled for you. Here’s a nice photo to give you one more chance to turn back. “We shot mostly on stages or on ...

Many women with multiple sclerosis (MS) notice a worsening of symptoms or progression just as menopause begins. While getting older is linked with disease progression in both men and women, hormones ...

Sunday's 30-16 win over the Chicago Bears was massive, on multiple levels, for Baltimore Ravens linebacker Roquan Smith. He saw his first action in about a month, as he had been sidelined with a ...

Zenas Biopharma’s autoimmune drug candidate has been tied to a 95% reduction in a type of brain lesions over 12 weeks in a phase 2 multiple sclerosis (MS) study. The midstage MoonStone study saw 116 ...